1 / 12

Non-Invasive Prenatal Testing Market Growth Strategies, Competitive Landscape

The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies).

ashwinisharma12
Download Presentation

Non-Invasive Prenatal Testing Market Growth Strategies, Competitive Landscape

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Non-Invasive Prenatal Testing Market Size Worth USD 8.75 Billion By 2027 Growth in the Non-Invasive Prenatal Testing (NIPT) industry is guided by the high probability of chromosomal anomalies with elevated maternal age, increased demand for non-invasive procedures over invasive approaches, enhanced NIPT reimbursement scenario and increased understanding of NIPT. www.emergenresearch.com

  2. Our Model Market Analysis Financial Analysis Distribution Channel Analysis Brand Analysis Custom Market Intelligence Competitor Analysis Product Analysis Custom Research www.emergenresearch.com Demand Analysis Risk Analysis

  3. Business Plan Parameters End Use Analysis Demand Availability Analytics Market Entry Strategy Restructuring & Revival New Product Strategy Product Planning / Strategy SWOT Analysis Marketing / Distribution Channel Feasibility www.emergenresearch.com Customer Identification Survey Competitive Landscape / M&A Feasibility www.emergenresearch.com

  4. Industries We Cater to Food & Beverages Foods & Beverage, Food Ingredients, Food Processing and Equipment, Food Testing and Supply Chain, Health Food and Sports Nutrition, Frozen and Processed Food, Household, Retail Power & Energy Oil and Gas, Electricity, Energy Storage, Environmental, Renewable Energy Automotive Services Information and Tech Electric and Hybrid Vehicles, Off Highway and On Highway Vehicles, Aftermarket and Maintenance, Automotive Parts, Interior and Exterior Materials, Automotive electronics and Systems Data Security, Cloud Computing, IoT and Digitalization, Robotics, Telecom and Networking, Software and Services, Analytics, Semiconductor, Internet and E-Commerce www.emergenresearch.com Pharma & Healthcare Materials and Chemicals Medical Devices, Therapeutics, Biotechnology, Medical Imaging, Healthcare IT, Hospital Management, Diagnostics, Laboratory Equipment, Pharmaceutical Organic Chemicals, Disinfectants and Preservatives, Adhesives and Sealants, Polymers and Resins, Petrochemicals, Agrochemicals and Fertilizers, Paints and Coatings 5

  5. Market Summary The global Non-Invasive Prenatal Testing Market is forecasted to reach USD 8.75 Billion by 2027, according to a new report by Emergen Research. Non-invasive prenatal testing (NIPT), commonly known as cell-free DNA testing, is regarded as a significant extension to the variety of diagnostic methods used to detect fetal chromosome defects. NIPT is also considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). NIPT enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes. Despite NIPT being accessible in growing amounts of regions, there is a major commercial push expected to assist consumer expansion in the projected years. NIPT was confirmed through similarities with standard prenatal aneuploidy screening and found to be a beneficial screening procedure with keen sensitivity and specificity. Increasing popularity among pregnant women as an alternative to amniocentesis and awareness of prenatal genetic problems drives non-invasive prenatal testing. With the increasing occurrence of pregnancy and complications, non-invasive prenatal testing is expected to become a routine procedure in the future, replacing other, riskier screening procedures. NIPT has more than 99% identification sensitivity and shows screening in less time than other prenatal screening forms. So few players provide non-invasive pregnancy monitoring. The high cost of research and the interim diagnostic method restrains business expansion. Read More : https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market www.emergenresearch.com

  6. Market Summary Further key findings from the report suggest Based on the method, ultrasound detection generated a revenue of USD 0.86 billion in 2019 and believed to rise with a CAGR of 14.0% in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb. The hospital segment expected to grow with a CAGR of 14.1% in the forecasted period due to the growing introduction of non-invasive prenatal testing coupled with rapid technological developments and groundbreaking acceptance strategies. North America dominated the market for Non-Invasive Prenatal Testing in 2019 due to the availability of technologically advanced healthcare research system, the region's production of WGS. The North America region held approximately 48.8% of the market, followed by Europe, which contains around 25.4% market in the year 2019. Key participants include Yourgene Health, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, GE Healthcare, PerkinElmer Inc., BGI, and Natera Inc., among others. Request Free Sample @ https://www.emergenresearch.com/request-sample/16 www.emergenresearch.com

  7. Market Summary • EmergenResearch has segmented into the global Non-Invasive Prenatal Testing market based on the method, end-use, application, and region: • Method Outlook (Revenue, USD Billion; 2017-2027) • Ultrasound Detection • Biochemical Screening Tests • Cell-free DNA in Maternal Plasma Tests • Others • End-Use Outlook (Revenue, USD Billion; 2017-2027) • Diagnostic Laboratories • Hospitals • Research Centers • Clinics • Application Outlook (Revenue, USD Billion; 2017-2027) • Trisomy • Microdeletion Syndrome • Others • Request customization @ https://www.emergenresearch.com/request-for-customization/16

  8. MARKETSEGMENTATION www.emergenresearch.com

  9. Regional Share Dynamics www.emergenresearch.com

  10. LATEST PUBLICATIONS Gut Microbiome Test Market https://www.emergenresearch.com/industry-report/gut-microbiome-test-market Ground Defense System Market https://www.emergenresearch.com/industry-report/ground-defense-system-market Human Microbiome Market https://www.emergenresearch.com/industry-report/human-microbiome-market Molecular Forensics Market https://www.emergenresearch.com/industry-report/molecular-forensics-market Automatic Weapons Market https://www.emergenresearch.com/industry-report/automatic-weapons-market Mobile C-Arms Market https://www.emergenresearch.com/industry-report/mobile-c-arms-market Gallium Nitride Market https://www.emergenresearch.com/industry-report/gallium-nitride-market www.emergenresearch.com

  11. At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade. Our expertise umbrellas the technological environment of all major industries, and our services help you map your actions to ensure optimal yield. Our analysts utilize their market proficiency to offer actionable insights that help our clients implement profitable strategies and optimize their return on investment. Our services are wide-ranging, right from technological environment analysis to technological profiling that highlights the existing opportunities in the market you can capitalize on to stay ahead of your competitors. About Us www.emergenresearch.com

  12. Lets Talk; Contact Information Reach out to us and our Research Executives will ensure you get the report that meets all your requirements and address all your concerns. 14671 110 Avenue, Surrey, British Columbia, V3R2A9 www.emergenresearch.com www.emergenresearch.com sales@emergenresearch.com +1 (604) 757-9756

More Related